Peptide-based LDH5 inhibitors enter cancer cells and impair proliferation.

Saved in:
Bibliographic Details
Title: Peptide-based LDH5 inhibitors enter cancer cells and impair proliferation.
Authors: Nadal-Bufí F; Queensland University of Technology, School of Biomedical Sciences and Translational Research Institute, Brisbane, QLD, 4102, Australia., Chan LY; Institute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane, QLD, 4072, Australia., Mohammad HH; Department of Biology and Biochemistry, University of Bath, Bath, BA2 7AY, UK.; Department of Pharmacy, College of Pharmacy, Knowledge University, Erbil, 44001, Kurdistan Region, Iraq., Mason JM; Department of Biology and Biochemistry, University of Bath, Bath, BA2 7AY, UK., Salomon C; Exosome Biology Laboratory, Centre for Clinical Diagnostics, The University of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital, The University of Queensland, Brisbane, QLD, 4029, Australia.; Departamento de Investigación, Postgrado y Educación Continua (DIPEC), Facultad de Ciencias de la Salud, Universidad del Alba, 8320000, Santiago, Chile., Lai A; Exosome Biology Laboratory, Centre for Clinical Diagnostics, The University of Queensland Centre for Clinical Research, Royal Brisbane and Women's Hospital, The University of Queensland, Brisbane, QLD, 4029, Australia., Thompson EW; Queensland University of Technology, School of Biomedical Sciences and Translational Research Institute, Brisbane, QLD, 4102, Australia., Craik DJ; Institute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane, QLD, 4072, Australia., Kaas Q; Institute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane, QLD, 4072, Australia., Henriques ST; Queensland University of Technology, School of Biomedical Sciences and Translational Research Institute, Brisbane, QLD, 4102, Australia. sonia.henriques@qut.edu.au.; Institute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane, QLD, 4072, Australia. sonia.henriques@qut.edu.au.
Source: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2022 Nov 27; Vol. 79 (12), pp. 606. Date of Electronic Publication: 2022 Nov 27.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-9071 (Electronic) Linking ISSN: 1420682X NLM ISO Abbreviation: Cell Mol Life Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1420-9071
DOI:10.1007/s00018-022-04633-3